Related Experiment Video
Updated: Nov 9, 2025

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
Published on: June 20, 2015
Impaired TRPV4-eNOS signaling in trabecular meshwork elevates intraocular pressure in glaucoma
Pinkal D Patel1, Yen-Lin Chen2, Ramesh B Kasetti1
1Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107.
Primary Open Angle Glaucoma (POAG) involves trabecular meshwork (TM) dysfunction. Our study reveals that impaired TRPV4 channels in TM cells disrupt TM function, leading to elevated intraocular pressure (IOP) in glaucoma.
Area of Science:
- Ophthalmology
- Cell Biology
- Physiology
Background:
- Primary Open Angle Glaucoma (POAG) is a leading cause of irreversible vision loss.
- Trabecular meshwork (TM) dysfunction is linked to elevated intraocular pressure (IOP) in POAG, but mechanisms are unclear.
- Transient Receptor Potential Vanilloid 4 (TRPV4) channels regulate Ca2+ entry and are implicated in cellular function.
Purpose of the Study:
- To investigate the role of TRPV4 channels in human TM cells and their involvement in IOP regulation.
- To explore the link between TRPV4 channel activity, endothelial nitric oxide synthase (eNOS), and IOP in glaucoma.
- To determine if impaired TRPV4-eNOS signaling contributes to TM dysfunction in POAG.
Main Methods:
- Investigated Ca2+ entry via TRPV4 channels in human TM cells under fluid flow.
- Utilized TM-specific TRPV4 knockout mice to assess IOP regulation.
- Examined the effect of pharmacological TRPV4 activation on aqueous humor outflow and IOP in mice.
- Assessed TRPV4-eNOS signaling in TM and Schlemm's canal cells.
- Analyzed TRPV4 channel activity and signaling in glaucomatous human TM cells.
Main Results:
- Direct evidence of Ca2+ entry through TRPV4 channels in human TM cells, activated by fluid flow.
- TM-specific TRPV4 knockout mice exhibited elevated IOP.
- Pharmacological TRPV4 activation lowered IOP and improved outflow facility in mice.
- TRPV4 activated eNOS in TM cells, crucial for IOP reduction; this signaling was more pronounced in TM cells than Schlemm's canal cells.
- Glaucomatous human TM cells displayed impaired TRPV4 activity and disrupted TRPV4-eNOS signaling, with reduced flow/shear stress activation.
Conclusions:
- TRPV4-eNOS signaling plays a critical role in regulating IOP.
- Impaired TRPV4 channel activity in TM cells contributes to TM dysfunction and elevated IOP in POAG.
- Targeting TRPV4 channels may offer a therapeutic strategy for glaucoma.
More Related Videos
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
10:10Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment